Nanosonics (OTCMKTS:NNCSF) Shares Down 17.5% – Here’s What Happened

Nanosonics Limited (OTCMKTS:NNCSF) shares fell 17.5% during mid-day trading on Friday . The company traded as low as $2.16 and last traded at $2.31. 2,600 shares were traded during mid-day trading, an increase of 117% from the average session volume of 1,200 shares. The stock had previously closed at $2.80.

Wall Street Analyst Weigh In

Separately, Royal Bank Of Canada raised shares of Nanosonics from an “underperform” rating to a “sector perform” rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Nanosonics Trading Down 17.5%

The company has a fifty day simple moving average of $2.43 and a 200-day simple moving average of $2.64.

Nanosonics Company Profile

Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.

The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.